Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

US Patent 7972801 · Granted Jul 5, 2011

Estimated economic value: $32,591,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining and reducing immunoresistance to botulinum toxin therapy using botul2012
Bont/a peptides and methodsof predicting and reducing immunoresistance to botuli2012
Determining and reducing immunoresistance to a botulinum toxin therapy using bot2011
Tolerogizing compositions comprising botulinum toxin type B peptides2010
Determining and reducing immunoresistance to a botulinum toxin therapy using bot2010
Determining and reducing immunoresistance to a Botulinum toxin therapy using Bot2010
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2009
Molecular-specific urokinase antibodies2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2008
Botulinum toxin A peptides and methods of predicting and reducing immunoresista2008
PVA or PEG conjugates of peptides for epitope-specific immunosuppression2000